| Aug 14 2023 |
FDA Issues Draft Guidance on Facility Registration under MoCRA |
Bergeson & Campbell, P.C. |
| Aug 11 2023 |
A&W Settles “Aged Vanilla” Class Action |
Keller and Heckman LLP |
| Aug 10 2023 |
Remedies as Big as Your Bamba |
McDermott Will & Schulte LLP |
| Aug 10 2023 |
The Tax Implications of Purchasing Craft Producers in the First Half of a Year |
McDermott Will & Schulte LLP |
| Aug 10 2023 |
Increase in Foodborne Illnesses Expected due to Climate Change |
Keller and Heckman LLP |
| Aug 10 2023 |
EPA Announces New Webinar Series on the Use of NAMs to Reduce Animal Testing |
Bergeson & Campbell, P.C. |
| Aug 10 2023 |
TRI PFAS Obligations May Expand Considerably |
CMBG3 Law |
| Aug 10 2023 |
FDA Draft Guidance Provides Further Details on New Cosmetic Product Facility Registration and Product Listing Requirements |
ArentFox Schiff LLP |
| Aug 10 2023 |
Modernization of Cosmetics Regulation Act of 2022 |
ArentFox Schiff LLP |
| Aug 10 2023 |
TSCA Section 21 Citizen Petition Seeks Prohibition of 6PPD in Tires |
Bergeson & Campbell, P.C. |
| Aug 10 2023 |
Cosmetic Product Registration and Listing Under MoCRA Comes Closer |
Beveridge & Diamond PC |
| Aug 9 2023 |
FDA Issues Final Administrative Actions on Partially Hydrogenated Oils in Foods |
Keller and Heckman LLP |
| Aug 9 2023 |
FDA Publishes Draft Guidance on Cosmetic Product Facility Registration and Cosmetic Product Listing |
Mintz |
| Aug 9 2023 |
PFAS MDL Settlements Face Additional Questions |
CMBG3 Law |
| Aug 8 2023 |
EUON Publishes Study Identifying Status of Animal-Free Test Methods for Use on Nanomaterials |
Bergeson & Campbell, P.C. |
| Aug 8 2023 |
Third Party Administrator & Pharmacy Benefit Manager 2023 Newsletter |
Polsinelli PC |
| Aug 8 2023 |
FDA Issues Draft Guidance on Registration of Cosmetic Product Facilities and Products |
Keller and Heckman LLP |
| Aug 8 2023 |
The FTC Finalizes Changes to Endorsement Guides |
Epstein Becker & Green, P.C. |
| Aug 8 2023 |
Alabama Medical Cannabis Update: August 10 Appears to Be the Day |
Bradley Arant Boult Cummings LLP |
| Aug 8 2023 |
DEA: Potential New Telemedicine Special Registration for Controlled Substances Prescribing to be Discussed in Special Listening Sessions |
Foley & Lardner LLP |
| Aug 7 2023 |
A Watched Pot Never Boils: SAFE Banking on the Backburner Again |
Bradley Arant Boult Cummings LLP |
| Aug 7 2023 |
California Judge Certifies Class in Bigelow Tea False Advertising Lawsuit |
Keller and Heckman LLP |
| Aug 4 2023 |
FDA Announces Public Meeting to Modernize Recalls |
Keller and Heckman LLP |
| Aug 4 2023 |
Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy |
McDermott Will & Schulte LLP |
| Aug 3 2023 |
OECD Publishes Consensus Document on Environmental Considerations for the Release of Transgenic Plants |
Bergeson & Campbell, P.C. |
| Aug 3 2023 |
Good News, Bad News: Congress Wants to Help the Hemp Industry |
Bradley Arant Boult Cummings LLP |
| Aug 3 2023 |
The Secret to Success: Protecting Your Cannabis Trade Secrets |
Bradley Arant Boult Cummings LLP |
| Aug 2 2023 |
EC Committee Updates Guidance on the Safety Assessment of Nanomaterials in Cosmetics |
Bergeson & Campbell, P.C. |
| Aug 2 2023 |
AAFCO Approves New Model Pet Food and Specialty Pet Food Regulations for Pet Food Packaging |
Keller and Heckman LLP |
| Aug 2 2023 |
FDA Warns “Natural” Birth Control Company: Three Takeaways from the NOV Letter |
Mintz |
| Aug 1 2023 |
BETO Will Host Bioenergy Cybersecurity Workshop on September 11, 2023 |
Bergeson & Campbell, P.C. |
| Aug 1 2023 |
Lawsuit Against Starbucks Dismissed; Sanctions Against Plaintiff’s Attorney Considered |
Keller and Heckman LLP |
| Aug 1 2023 |
Unpacking Averages: Analyzing the Relationship Between MDRs and Recalls |
Epstein Becker & Green, P.C. |
| Aug 1 2023 |
Cancer Moonshot Initiative Adds Precision Surgery Effort |
Foley & Lardner LLP |
| Aug 1 2023 |
EPA Adds Nine PFAS Chemicals to The Toxics Release Inventory Reporting List |
Babst, Calland, Clements & Zomnir, P.C. |
